Theralase Technologies Inc.
TLTFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -3.4% | -6% | 45.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 53.6% | 52.5% | 55.2% | 39.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -383.2% | -397.5% | -430.4% | -529% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -411.8% | -427.1% | -459.8% | -565.1% |
| EPS Diluted | -0.018 | -0.021 | -0.025 | -0.022 |
| % Growth | 14.9% | 17.5% | -16.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |